Effect of 3-hydroxy-3-methylglutarate treatment on plasma ketone bodies, triglycerides, and HDL-cholesterol in streptozotocin-diabetic rats

Clin Biochem. 1987 Jun;20(3):201-5. doi: 10.1016/s0009-9120(87)80121-2.

Abstract

3-Hydroxy-3-methylglutaric acid administration to streptozotocin-diabetic rats produced a net decrease of plasma ketone bodies and triglycerides together with a slight decrease of total cholesterol. A nonsignificant enhancement of HDL-cholesterol and a negligible change in HDL-phospholipid was also observed. The effect of 3-hydroxy-3-methylglutarate was dose dependent and was more evident with the compound intraperitoneally injected than orally administered with drinking water. [14C]-3-hydroxy-3-methylglutarate was administered either orally or intraperitoneally both to diabetic and control groups of animals, and a higher radioactivity accumulated in liver and kidneys of diabetic rats compared to the controls. The possible mechanism of action of 3-hydroxy-3-methylglutarate is briefly discussed.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cholesterol, HDL / blood*
  • Diabetes Mellitus, Experimental / blood*
  • Female
  • Glutarates / pharmacology*
  • Ketone Bodies / blood*
  • Meglutol / pharmacokinetics
  • Meglutol / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Triglycerides / blood*

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Glutarates
  • Ketone Bodies
  • Triglycerides
  • Meglutol